APXT
Apex Treasury Corporation Class A
There isn't enough reported data to score APXT yet.
BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
APXT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
APXT's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like APXT.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
APXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 50x | $10.21 | — |
| Cheap | 85x | $16.96 | +66% |
| Fair | 86x | $17.10 | +68% |
| Expensive | 108x | $21.52 | +111% |
Historical ranges are pointers, not guarantees.
APXT has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
APXT Forward outlook
There aren't enough analyst estimates for APXT to show an outlook.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
APXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.20 | +$1.34 |
| Q2 2026 | $0.16 | +$1.29 |
| Q1 2026 | $0.12 | +$1.32 |
APXT has returned to profit: it earned $0.20 per share over the past year, after losing money the year before.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK has the edge over APXT in the latest year-over-year earnings comparison.
APXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $114.7M | -60% |
APXT's revenue has slid since its 2024 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 13% | +5.5 points |
| Q1 2025 | 3.5% | +28 points |
| Q4 2024 | 7.2% | N/A |
| Q3 2024 | 8.6% | N/A |
| Q2 2024 | -2.7% | N/A |
| Q2 2021 | -24% | N/A |
APXT's operating margin was 13% last quarter, up 15 points from the same quarter a year ago.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over APXT in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
APXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$211.7K | -$211.7K |
| Q2 2026 | -$23.4M | -228% |
| Q1 2026 | $23M | +$24M |
| Q4 2025 | $29M | -66% |
| Q3 2025 | $0 | -100% |
| Q2 2021 | -$243 | +$210.3K |
| Q1 2021 | -$358.1K | +$24.8K |
| Q2 2020 | -$210.5K | -$210.5K |
APXT's free cash flow was $28M over the past year, down 73% from the year before. Free cash flow isn't a meaningful measure for financial services companies like APXT.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over APXT on cash flow, with more consistent year-over-year improvement.
APXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -40.5x | Net Cash |
| Q1 2025 | -41.4x | Net Cash |
APXT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like APXT.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
APXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.7 | Overbought |
| Stochastic | 80.0 | Overbought |
APXT's weekly RSI is 76 (overbought) and its Stochastic is 80 (overbought).
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
APXT PE vs Financial Services Sector
| Metric | APXT | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 13x | 287% above |
| PE % | 0 | 12 | 12 pts below |
APXT is trading at 50x earnings, a 287% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK has the edge over APXT on valuation relative to its sector.
APXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 0.5% above |
| 20 week MA | $10.1 | 0.8% above |
| 50 week MA | $10.0 | 1.8% above |
BLK has stronger trend alignment. APXT is above 3 of 3 weekly averages versus BLK above 5 of 5.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
APXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $9.89 | $9.88 | -0.1% |
| 2026 YTD | $9.88 | $10.2 | +3.3% |
APXT has finished every year since 2025 lower, and it's up 3.3% so far in 2026.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has the edge over APXT on returns for 2026, with the stronger performance.